NAD+ 전구체

Effects of Supplementation with NAD +  Precursors on Metabolic Syndrome Parameters: A Systematic Review and Meta-Analysis.

1. Horm Metab Res. 2024 Nov;56(11):818-826. doi: 10.1055/a-2382-6829. Epub 2024 Aug 7. Effects of Supplementation with NAD +  Precursors on Metabolic Syndrome Parameters: A Systematic Review and Meta-Analysis. Oliveira-Cruz A(1), Macedo-Silva A(2), Silva-Lima D(1), Sanchez-Almeida J(1), Cruz-Co

The differential impact of three different NAD(+) boosters on circulatory NAD and microbial metabolism in humans.

2. Nat Metab. 2026 Jan;8(1):62-73. doi: 10.1038/s42255-025-01421-8. Epub 2026 Jan 15. The differential impact of three different NAD(+) boosters on circulatory NAD and microbial metabolism in humans. Christen S(1), Redeuil K(1), Goulet L(1), Giner MP(1), Breton I(1), Rota R(1), Frézal A(1), Naz

Longitudinal metabolomics analysis reveals the acute effect of cysteine and NAC included in the combined metabolic activators.

3. Free Radic Biol Med. 2023 Aug 1;204:347-358. doi: 10.1016/j.freeradbiomed.2023.05.013. Epub 2023 May 26. Longitudinal metabolomics analysis reveals the acute effect of cysteine and NAC included in the combined metabolic activators. Yang H(1), Li X(2), Jin H(3), Turkez H(4), Ozturk G(5), Dogan

Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin.

4. Aging Cell. 2023 Jan;22(1):e13754. doi: 10.1111/acel.13754. Epub 2022 Dec 14. Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin. Vreones M(1), Mustapic M(1), Moaddel R(1), Pucha KA(1), Love

MIB-626, an Oral Formulation of a Microcrystalline Unique Polymorph of β-Nicotinamide Mononucleotide, Increases Circulating Nicotinamide Adenine Dinucleotide and its Metabolome in Middle-Aged and Older Adults.

5. J Gerontol A Biol Sci Med Sci. 2023 Jan 26;78(1):90-96. doi: 10.1093/gerona/glac049. MIB-626, an Oral Formulation of a Microcrystalline Unique Polymorph of β-Nicotinamide Mononucleotide, Increases Circulating Nicotinamide Adenine Dinucleotide and its Metabolome in Middle-Aged and Older Adults

Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study.

6. J Int Soc Sports Nutr. 2021 Jul 8;18(1):54. doi: 10.1186/s12970-021-00442-4. Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study. Liao B(#)(1), Zhao Y(#)(2), Wang D(3)(2), Zhang X(4), Hao X(5), Hu M(3). Author information:

NAD+-Precursor Supplementation With L-Tryptophan, Nicotinic Acid, and Nicotinamide Does Not Affect Mitochondrial Function or Skeletal Muscle Function in Physically Compromised Older Adults.

7. J Nutr. 2021 Oct 1;151(10):2917-2931. doi: 10.1093/jn/nxab193. NAD+-Precursor Supplementation With L-Tryptophan, Nicotinic Acid, and Nicotinamide Does Not Affect Mitochondrial Function or Skeletal Muscle Function in Physically Compromised Older Adults. Connell NJ(1), Grevendonk L(1), Fealy CE

Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19.

8. Adv Sci (Weinh). 2021 Sep;8(17):e2101222. doi: 10.1002/advs.202101222. Epub 2021 Jun 28. Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19. Altay O(1)(2), Arif M(1), Li X(1), Yang H(1), Aydın M(3), Alkurt G(4), Kim W(1), Akyol D(4), Zhang C(1)(5), Dinler-Doganay

NAD⁺ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence.

9. Ageing Res Rev. 2026 Apr;116:103057. doi: 10.1016/j.arr.2026.103057. Epub 2026 Feb 6. NAD⁺ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence. Gallagher C(1), Emmanuel OO(2). Author information: (1)Allure Management, 150 Allend

A systematic review of the therapeutic potential of nicotinamide adenine dinucleotide precursors for cognitive diseases in preclinical rodent models.

10. BMC Neurosci. 2025 Mar 3;26(1):17. doi: 10.1186/s12868-025-00937-9. A systematic review of the therapeutic potential of nicotinamide adenine dinucleotide precursors for cognitive diseases in preclinical rodent models. Qader MA(1), Hosseini L(2), Abolhasanpour N(3), Oghbaei F(4), Maghsoumi-No

Supplementation with NAD+ Precursors for Treating Alzheimer's Disease: A Metabolic Approach.

11. J Alzheimers Dis. 2024;101(s1):S467-S477. doi: 10.3233/JAD-231277. Supplementation with NAD+ Precursors for Treating Alzheimer's Disease: A Metabolic Approach. Alghamdi M(1)(2), Braidy N(1). Author information: (1)Centre for Healthy Brain Ageing, School of Psychiatry, University of New Sout

NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis.

12. Exp Gerontol. 2020 Apr;132:110831. doi: 10.1016/j.exger.2020.110831. Epub 2020 Jan 7. NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis. Braidy N(1), Liu Y(2). Author information: (1)Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wal